/

Empresas

Ga

No verificado

Galapagos NV

Sobre qué escribimos

BiotecnologíaPolítica Internacional

32 Comunicados de prensa

Ver todos los comunicados de prensa

25/11/2025

Biotecnología

Política Internacional

Galapagos Receives Transparency Notifications from Bank of America

Fuente

Editor

1.00

0

05/11/2025

Biotecnología

Política Internacional

Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update

Fuente

Editor

1.00

0

03/11/2025

Biotecnología

Política Internacional

Galapagos to Present New Data from Cell Therapy Program at ASH 2025

Fuente

Editor

1.00

0

30/10/2025

Biotecnología

Política Internacional

Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development

Fuente

Editor

1.00

0

23/10/2025

Biotecnología

Política Internacional

Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors

Fuente

Editor

1.00

0

20/10/2025

Biotecnología

Política Internacional

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

Fuente

Editor

1.00

0

16/10/2025

Biotecnología

Política Internacional

Galapagos Announces Appointment of Fred Blakeslee as General Counsel

Fuente

Editor

1.00

0

01/10/2025

Biotecnología

Política Internacional

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business

Fuente

Editor

1.00

0

07/08/2025

Biotecnología

Política Internacional

Galapagos Creates New Subscription Right Plan

Fuente

Editor

1.00

0

05/08/2025

Biotecnología

Política Internacional

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0